♥
ISIN : INE933A01014
NSE : LYKALABS
BSE : 500259
Face Value : 10
Industry : Pharmaceuticals & Drugs
EPS : -0.79
EPS (TTM) : -3.06
Price to Earning (P/E) : -127.10
Book Value : 17.86
Price to Bookvalue (P/B) : 5.62
Dividend Yield : 0 %
Return on Equity (ROE) : -6.02 %
Return on Capital Employed (ROCE) : 3.26 %
Lyka Labs Limited
ISIN : INE933A01014
NSE : LYKALABS
BSE : 500259
Face Value : 10
Industry : Pharmaceuticals & Drugs
EPS : -0.79
EPS (TTM) : -3.06
Price to Earning (P/E) : -127.10
Book Value : 17.86
Price to Bookvalue (P/B) : 5.62
Dividend Yield : 0 %
Return on Equity (ROE) : -6.02 %
Return on Capital Employed (ROCE) : 3.26 %
Lyka Labs share price(02-Apr-2026) | |
|---|---|
| Open / Close | 0 - 0 NAN % |
| Low / High | 0 - 0 NAN % |
| Trade Volume | 0 |
| 52 Week Low / High | 0 - 0 NAN % |
| Open / Close | 53.75 - 55.05 2.4 % |
| Low / High | 49.5 - 56 13.1 % |
| Trade Volume | 3,386 |
| 52 Week Low / High | 44.49 - 128.6 189.1 % |
-
YOU MAY ALSO LIKE
- Stock market course tutorial
Stock Market Investment Course explained in simple words. - High dividend stocks
High dividend yield stocks on Stock exchange NSE and BSE - Low PE ratio stocks
Undervalued, low PE ratio stocks on Stock exchange NSE and BSE - How much money do you need to retire
Know how much money do you need to retire, before how much to invest ? - CAGR Calculator
Check your investment returns using our CAGR / Investment Growth Calculator - Share Market basics for beginners
Share Market jargons in simple terms
CONSOLIDATED QUARTERLY RESULT FOR LYKA LABS LIMITED
| Date End | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| No of months | 3 months | 3 months | 3 months | 3 months | 3 months | 3 months | 3 months | 3 months | 3 months | 3 months |
| Net Sales | 351.85 | 274.92 | 255.27 | 178.16 | 222.39 | 228.77 | 279.86 | 325.64 | 277.67 | 301.14 |
| Total Income | 357.18 | 282.1 | 267.16 | 188.8 | 226.67 | 232.53 | 282.33 | 331.06 | 280.58 | 306.73 |
| Total Expenditure | 225.82 | 211.9 | 204.98 | 156.02 | 189.43 | 202.33 | 238.07 | 257 | 257.38 | 264.07 |
| Other Income | 5.33 | 7.18 | 11.9 | 10.65 | 4.29 | 3.76 | 2.46 | 5.42 | 2.91 | 5.59 |
| Operating Profit | 131.36 | 70.2 | 62.18 | 32.78 | 37.24 | 30.2 | 44.26 | 74.06 | 23.2 | 42.66 |
| Interest | 29.9 | 29.07 | 30.32 | 30.84 | 28.47 | 13.51 | 11.88 | 12.78 | 10.74 | 6.47 |
| Exceptional Items | -28.03 | 2.34 | -2.07 | -70.11 | -4.11 | -4.35 | 0.24 | |||
| PBDT | 73.43 | 43.47 | 29.79 | -68.17 | 4.66 | 16.69 | 28.03 | 61.28 | 12.7 | 36.19 |
| Depreciation | 94.58 | 35.86 | 36.21 | 34.74 | 34.66 | 34.67 | 35.95 | 28.42 | 28.99 | 17.57 |
| Profit Before Tax | -21.15 | 7.61 | -6.42 | -102.91 | -30 | -17.98 | -7.92 | 32.86 | -16.29 | 18.62 |
| Tax | 128.75 | 0.53 | -3 | 2.32 | -0.04 | 1.32 | -1.77 | 12.72 | 4.59 | 5.73 |
| Profit After Tax | -149.9 | 7.08 | -3.42 | -105.23 | -29.96 | -19.3 | -6.15 | 20.14 | -20.88 | 12.89 |
| Net Profit | -149.9 | 7.08 | -3.42 | -105.23 | -29.96 | -19.3 | -6.15 | 20.14 | -20.88 | 12.89 |
| Equity Capital | 286.9 | 286.9 | 286.9 | 286.9 | 306.9 | 330.9 | 330.9 | 330.9 | 330.9 | 356.9 |
| Face Value (IN RS) | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 |
| Calculated EPS | -5.25 | 0.21 | -0.13 | -3.63 | -0.98 | -0.56 | -0.15 | 0.54 | -0.64 | 0.4 |
| Diluted Eps After Extraordinary Items | -5.26 | 0.2 | -0.14 | -3.64 | -1.05 | -0.57 | -0.16 | 0.53 | -3.83 | 0.4 |
| Diluted Eps Before Extraordinary Items | -5.26 | 0.2 | -0.14 | -3.64 | -1.05 | -0.57 | -0.16 | 0.53 | -3.83 | 0.4 |
STANDALONE QUARTERLY RESULT FOR LYKA LABS LIMITED
| Date End | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| No of months | 3 months | 3 months | 3 months | 3 months | 3 months | 3 months | 3 months | 3 months | 3 months | 3 months |
| Net Sales | 276.83 | 218.78 | 221.27 | 171.32 | 194.55 | 212.37 | 267.6 | 314.15 | 269.84 | 301.05 |
| Total Income | 283.43 | 225.62 | 231.66 | 182.46 | 200.7 | 216.65 | 270.64 | 319.4 | 273.74 | 307.24 |
| Total Expenditure | 161.21 | 159.58 | 173.96 | 149.13 | 167.24 | 186.8 | 228.24 | 255.63 | 247.69 | 260.5 |
| Other Income | 6.6 | 6.84 | 10.39 | 11.14 | 6.15 | 4.28 | 3.04 | 5.25 | 3.9 | 6.2 |
| Operating Profit | 122.22 | 66.04 | 57.7 | 33.33 | 33.46 | 29.85 | 42.4 | 63.77 | 26.05 | 46.74 |
| Interest | 29.1 | 28.01 | 29.14 | 30.42 | 28.13 | 13.33 | 11.71 | 12.59 | 10.35 | 6.51 |
| Exceptional Items | -28.03 | -0.01 | -1.37 | -68.97 | -1.39 | -0.45 | -0.1 | |||
| PBDT | 65.09 | 38.02 | 27.19 | -66.06 | 3.94 | 16.52 | 30.24 | 51.18 | 15.6 | 40.23 |
| Depreciation | 91.31 | 34.14 | 34.55 | 33.25 | 33.22 | 33.35 | 34.63 | 27.17 | 27.72 | 16.77 |
| Profit Before Tax | -26.22 | 3.88 | -7.36 | -99.31 | -29.28 | -16.83 | -4.39 | 24.01 | -12.12 | 23.46 |
| Tax | 126.13 | 0.61 | -3.4 | 2.83 | 0.75 | 0.37 | -1.47 | 10.37 | 4.1 | 5.96 |
| Profit After Tax | -152.35 | 3.27 | -3.96 | -102.14 | -30.03 | -17.2 | -2.92 | 13.64 | -16.22 | 17.5 |
| Net Profit | -152.35 | 3.27 | -3.96 | -102.14 | -30.03 | -17.2 | -2.92 | 13.64 | -16.22 | 17.5 |
| Equity Capital | 286.9 | 286.9 | 286.9 | 286.9 | 306.9 | 330.9 | 330.9 | 330.9 | 330.9 | 356.9 |
| Face Value (IN RS) | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 |
| Calculated EPS | -5.31 | 0.11 | -0.14 | -3.56 | -0.98 | -0.52 | -0.09 | 0.41 | -0.49 | 0.49 |
| Diluted Eps After Extraordinary Items | -5.32 | 0.11 | -0.15 | -3.57 | -1.05 | -0.54 | -0.1 | 0.4 | -0.5 | 0.49 |
| Diluted Eps Before Extraordinary Items | -5.32 | 0.11 | -0.15 | -3.57 | -1.05 | -0.54 | -0.1 | 0.4 | -0.5 | 0.49 |
CONSOLIDATED ANNUAL RESULT FOR LYKA LABS LIMITED
| Date End | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|
| No of months | 12 months | 12 months | 12 months |
| Net Sales | 1940.85 | 930.73 | 1111.95 |
| Total Income | 1961.79 | 964.74 | 1126.49 |
| Total Expenditure | 929.36 | 762.33 | 954.8 |
| Other Income | 20.94 | 34.01 | 14.55 |
| Operating Profit | 1032.43 | 202.41 | 171.69 |
| Interest | 201.29 | 118.7 | 48.91 |
| Exceptional Items | -65.19 | -73.94 | -4.11 |
| PBDT | 765.95 | 9.77 | 118.67 |
| Depreciation | 173.49 | 141.47 | 128.02 |
| Profit Before Tax | 592.46 | -131.7 | -9.35 |
| Tax | 208.04 | -0.19 | 16.86 |
| Profit After Tax | 384.42 | -131.51 | -26.21 |
| Net Profit | 384.42 | -131.51 | -26.21 |
| Equity Capital | 286.9 | 306.9 | 330.9 |
| Face Value (IN RS) | 10 | 10 | 10 |
| Reserves | -153.52 | 147.51 | 350.64 |
| Calculated EPS | 13.59 | -4.3 | -0.75 |
| Diluted Eps After Extraordinary Items | 13.57 | -4.63 | -0.79 |
| Diluted Eps Before Extraordinary Items | 13.57 | -4.63 | -0.79 |
STANDALONE ANNUAL RESULT FOR LYKA LABS LIMITED
| Date End | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|
| No of months | 12 months | 12 months | 12 months |
| Net Sales | 1643.49 | 805.93 | 1063.96 |
| Total Income | 1670.69 | 840.44 | 1080.44 |
| Total Expenditure | 668.5 | 649.92 | 918.37 |
| Other Income | 27.2 | 34.52 | 16.47 |
| Operating Profit | 1002.19 | 190.52 | 162.07 |
| Interest | 199.21 | 115.7 | 47.98 |
| Exceptional Items | -46.68 | -71.74 | -0.55 |
| PBDT | 756.3 | 3.08 | 113.54 |
| Depreciation | 153.89 | 135.16 | 122.87 |
| Profit Before Tax | 602.41 | -132.08 | -9.33 |
| Tax | 203.38 | 0.78 | 13.37 |
| Profit After Tax | 399.03 | -132.86 | -22.7 |
| Net Profit | 399.03 | -132.86 | -22.7 |
| Equity Capital | 286.9 | 306.9 | 330.9 |
| Face Value (IN RS) | 10 | 10 | 10 |
| Reserves | 157.49 | 457.36 | 662.39 |
| Calculated EPS | 13.91 | -4.33 | -0.69 |
| Diluted Eps After Extraordinary Items | 13.87 | -4.65 | -0.72 |
| Diluted Eps Before Extraordinary Items | 13.87 | -4.65 | -0.72 |
CONSOLIDATED PROFIT / LOSS FOR LYKA LABS LIMITED
| YEAR | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|---|
| No of Months | 12 months | 12 months | 12 months | 12 months |
| Gross Sales | 86.25 Cr | 194.08 Cr | 93.07 Cr | 111.2 Cr |
| Sales | 67.11 Cr | 183.59 Cr | 88.34 Cr | 105.13 Cr |
| Processing Charges / Service Income | 17.02 Cr | 9.61 Cr | 3.92 Cr | 3.86 Cr |
| Net Sales | 86.25 Cr | 194.08 Cr | 93.07 Cr | 111.2 Cr |
| Increase/Decrease in Stock | 3.06 Cr | -41.05 Lk | -1.21 Cr | -78.5 Lk |
| Raw Material Consumed | 34.91 Cr | 53.38 Cr | 38.76 Cr | 45.64 Cr |
| Opening Raw Materials | 3.22 Cr | 1.96 Cr | 3.13 Cr | 2.29 Cr |
| Purchases Raw Materials | 12.94 Cr | 28.11 Cr | 22.23 Cr | 33.46 Cr |
| Closing Raw Materials | 3.85 Cr | 3.13 Cr | 2.29 Cr | 3.6 Cr |
| Other Direct Purchases / Brought in cost | 22.6 Cr | 26.45 Cr | 15.69 Cr | 13.49 Cr |
| Power & Fuel Cost | 2.94 Cr | 3.92 Cr | 3.6 Cr | 3.93 Cr |
| Electricity & Power | 2.94 Cr | 3.92 Cr | 3.6 Cr | 3.93 Cr |
| Employee Cost | 14.57 Cr | 18.06 Cr | 18.61 Cr | 26.77 Cr |
| Salaries, Wages & Bonus | 12.33 Cr | 15.25 Cr | 16.22 Cr | 23.84 Cr |
| Contributions to EPF & Pension Funds | 80.32 Lk | 94.13 Lk | 84.18 Lk | 1.21 Cr |
| Workmen and Staff Welfare Expenses | 93.7 Lk | 1.31 Cr | 95.52 Lk | 1.1 Cr |
| Other Manufacturing Expenses | 3 Cr | 4.2 Cr | 5.09 Cr | 4.52 Cr |
| Processing Charges | 22.15 Lk | 42,000 | 34.24 Lk | 4.29 Lk |
| Repairs and Maintenance | 1.51 Cr | 1.53 Cr | 1.7 Cr | 1.63 Cr |
| General and Administration Expenses | 4.31 Cr | 6.29 Cr | 7.89 Cr | 9.39 Cr |
| Rent , Rates & Taxes | 78.73 Lk | 90.8 Lk | 1.73 Cr | 1.84 Cr |
| Insurance | 28.35 Lk | 30.81 Lk | 36.75 Lk | 30.94 Lk |
| Printing and stationery | 21.15 Lk | 15.88 Lk | 17.16 Lk | 37.32 Lk |
| Professional and legal fees | 1.84 Cr | 3.21 Cr | 2.7 Cr | 2.19 Cr |
| Traveling and conveyance | 44.29 Lk | 95.68 Lk | 2.01 Cr | 3.76 Cr |
| Selling and Distribution Expenses | 2.65 Cr | 5.75 Cr | 2.59 Cr | 4.7 Cr |
| Advertisement & Sales Promotion | 34.98 Lk | 63.57 Lk | 31.02 Lk | 1.11 Cr |
| Sales Commissions & Incentives | 90.94 Lk | 2.98 Cr | 30.5 Lk | 1.42 Cr |
| Freight and Forwarding | 1.39 Cr | 2.13 Cr | 1.97 Cr | 2.17 Cr |
| Miscellaneous Expenses | 1.14 Cr | 1.74 Cr | 89.67 Lk | 1.33 Cr |
| Total Expenditure | 66.57 Cr | 92.94 Cr | 76.23 Cr | 95.48 Cr |
| Other Income | 1.56 Cr | 2.09 Cr | 3.4 Cr | 1.45 Cr |
| Interest Received | 1.11 Cr | 1.34 Cr | 2.15 Cr | 86.15 Lk |
| Profit on sale of Fixed Assets | 2 Lk | 0 | 0 | 0 |
| Provision Written Back | 15,000 | 0 | 0 | 4.62 Lk |
| Foreign Exchange Gains | 4.39 Lk | 53.08 Lk | 40.19 Lk | 48.88 Lk |
| Operating Profit | 21.25 Cr | 103.24 Cr | 20.24 Cr | 17.17 Cr |
| Interest | 25.94 Cr | 20.13 Cr | 11.87 Cr | 4.89 Cr |
| Interest on Term Loan | 22.37 Cr | 14.54 Cr | 38.44 Lk | 0 |
| Bank Charges etc | 28.39 Lk | 24.04 Lk | 14.67 Lk | 11.9 Lk |
| PBDT | -4.69 Cr | 83.12 Cr | 8.37 Cr | 12.28 Cr |
| Depreciation | 8.32 Cr | 17.35 Cr | 14.15 Cr | 12.8 Cr |
| Profit Before Taxation & Exceptional Items | -13.02 Cr | 65.77 Cr | -5.78 Cr | -52.32 Lk |
| Exceptional Income / Expenses | -1.13 Cr | -6.52 Cr | -7.39 Cr | -41.06 Lk |
| Profit Before Tax | -14.14 Cr | 59.25 Cr | -13.17 Cr | -93.38 Lk |
| Provision for Tax | -4.05 Cr | 20.8 Cr | -1.87 Lk | 1.69 Cr |
| Current Income Tax | 44,000 | 22.44 Lk | 20.45 Lk | 1.87 Cr |
| Deferred Tax | -4.06 Cr | 20.58 Cr | -22.32 Lk | -18.26 Lk |
| Profit After Tax | -10.09 Cr | 38.44 Cr | -13.15 Cr | -2.62 Cr |
| Minority Interest | -1.46 Cr | 55.65 Lk | -5.94 Lk | 13.11 Lk |
| Consolidated Net Profit | -11.55 Cr | 39 Cr | -13.21 Cr | -2.49 Cr |
| Profit Balance B/F | -149.89 Cr | -161.45 Cr | -122.45 Cr | -135.66 Cr |
| Appropriations | -161.45 Cr | -122.45 Cr | -135.66 Cr | -138.15 Cr |
| Other Appropriation | 0 | 1,000 | 0 | 0 |
| Earnings Per Share | -4.03 | 13.59 | -4.3 | -0.75 |
| Adjusted EPS | -4.03 | 13.59 | -4.3 | -0.75 |
STANDALONE PROFIT / LOSS FOR LYKA LABS LIMITED
| YEAR | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|---|
| No of Months | 12 months | 12 months | 12 months | 12 months |
| Gross Sales | 62.26 Cr | 164.35 Cr | 80.59 Cr | 106.4 Cr |
| Sales | 44.73 Cr | 154.77 Cr | 76.31 Cr | 101.5 Cr |
| Processing Charges / Service Income | 16.27 Cr | 8.77 Cr | 2.66 Cr | 2.73 Cr |
| Net Sales | 62.26 Cr | 164.35 Cr | 80.59 Cr | 106.4 Cr |
| Increase/Decrease in Stock | 2.04 Cr | -40.44 Lk | -1.21 Cr | -78.6 Lk |
| Raw Material Consumed | 21.48 Cr | 31.27 Cr | 30.27 Cr | 43.73 Cr |
| Opening Raw Materials | 3.22 Cr | 1.96 Cr | 3.13 Cr | 2.29 Cr |
| Purchases Raw Materials | 12.94 Cr | 28.11 Cr | 22.23 Cr | 33.46 Cr |
| Closing Raw Materials | 3.85 Cr | 3.13 Cr | 2.29 Cr | 3.6 Cr |
| Other Direct Purchases / Brought in cost | 9.17 Cr | 4.33 Cr | 7.19 Cr | 11.58 Cr |
| Power & Fuel Cost | 2.91 Cr | 3.88 Cr | 3.57 Cr | 3.92 Cr |
| Electricity & Power | 2.91 Cr | 3.88 Cr | 3.57 Cr | 3.92 Cr |
| Employee Cost | 13.03 Cr | 16.22 Cr | 17.48 Cr | 26.01 Cr |
| Salaries, Wages & Bonus | 10.86 Cr | 13.51 Cr | 15.23 Cr | 23.14 Cr |
| Contributions to EPF & Pension Funds | 72.7 Lk | 88.84 Lk | 79.38 Lk | 1.18 Cr |
| Workmen and Staff Welfare Expenses | 92.76 Lk | 1.29 Cr | 94.92 Lk | 1.1 Cr |
| Other Manufacturing Expenses | 2.89 Cr | 4.13 Cr | 5.04 Cr | 4.49 Cr |
| Processing Charges | 22.15 Lk | 42,000 | 34.24 Lk | 4.29 Lk |
| Repairs and Maintenance | 1.4 Cr | 1.46 Cr | 1.65 Cr | 1.6 Cr |
| General and Administration Expenses | 3.78 Cr | 5.62 Cr | 7.11 Cr | 8.79 Cr |
| Rent , Rates & Taxes | 75.5 Lk | 86.51 Lk | 1.69 Cr | 1.79 Cr |
| Insurance | 24.81 Lk | 26.81 Lk | 29.73 Lk | 28.58 Lk |
| Printing and stationery | 21.15 Lk | 15.88 Lk | 17.16 Lk | 37.32 Lk |
| Professional and legal fees | 1.63 Cr | 3.02 Cr | 2.47 Cr | 2.01 Cr |
| Traveling and conveyance | 28.73 Lk | 64.98 Lk | 1.69 Cr | 3.47 Cr |
| Selling and Distribution Expenses | 1.23 Cr | 4.54 Cr | 1.84 Cr | 4.48 Cr |
| Advertisement & Sales Promotion | 5.89 Lk | 57.62 Lk | 22.48 Lk | 1.1 Cr |
| Sales Commissions & Incentives | 77.13 Lk | 2.85 Cr | 21.47 Lk | 1.4 Cr |
| Freight and Forwarding | 40.29 Lk | 1.11 Cr | 1.4 Cr | 1.97 Cr |
| Miscellaneous Expenses | 48.06 Lk | 1.6 Cr | 88.98 Lk | 1.2 Cr |
| Total Expenditure | 47.84 Cr | 66.85 Cr | 64.99 Cr | 91.84 Cr |
| Other Income | 2.21 Cr | 2.72 Cr | 3.45 Cr | 1.65 Cr |
| Interest Received | 1.39 Cr | 1.59 Cr | 2.21 Cr | 1.1 Cr |
| Foreign Exchange Gains | 0 | 35.27 Lk | 35.95 Lk | 40.39 Lk |
| Operating Profit | 16.64 Cr | 100.22 Cr | 19.05 Cr | 16.21 Cr |
| Interest | 25.55 Cr | 19.92 Cr | 11.57 Cr | 4.8 Cr |
| Interest on Term Loan | 22.37 Cr | 14.54 Cr | 38.44 Lk | 0 |
| Bank Charges etc | 14.48 Lk | 17.77 Lk | 12.77 Lk | 11.01 Lk |
| PBDT | -8.92 Cr | 80.3 Cr | 7.48 Cr | 11.41 Cr |
| Depreciation | 8.05 Cr | 15.39 Cr | 13.52 Cr | 12.29 Cr |
| Profit Before Taxation & Exceptional Items | -16.97 Cr | 64.91 Cr | -6.03 Cr | -87.74 Lk |
| Exceptional Income / Expenses | -1.43 Cr | -4.67 Cr | -7.17 Cr | -5.51 Lk |
| Profit Before Tax | -18.4 Cr | 60.24 Cr | -13.21 Cr | -93.25 Lk |
| Provision for Tax | -3.94 Cr | 20.34 Cr | 7.82 Lk | 1.34 Cr |
| Current Income Tax | 0 | 0 | 20.7 Lk | 1.6 Cr |
| Deferred Tax | -3.94 Cr | 20.34 Cr | -12.88 Lk | -26.33 Lk |
| Profit After Tax | -14.46 Cr | 39.9 Cr | -13.29 Cr | -2.27 Cr |
| Consolidated Net Profit | -14.46 Cr | 39.9 Cr | -13.29 Cr | -2.27 Cr |
| Profit Balance B/F | -113.54 Cr | -127.99 Cr | -88.09 Cr | -101.38 Cr |
| Appropriations | -127.99 Cr | -88.09 Cr | -101.38 Cr | -103.65 Cr |
| Earnings Per Share | -5.04 | 13.91 | -4.33 | -0.69 |
| Adjusted EPS | -5.04 | 13.91 | -4.33 | -0.69 |
CONSOLIDATED CASH FLOW FOR LYKA LABS LIMITED
| Year End | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|---|
| No of Months | 12 months | 12 months | 12 months | 12 months |
| Profit Before Tax | -14.14 Cr | 59.25 Cr | -13.17 Cr | -93.38 Lk |
| Adjustment | 35.4 Cr | 41.93 Cr | 31.78 Cr | 18.02 Cr |
| Changes In working Capital | -11.64 Cr | -21.01 Cr | -9.86 Cr | -13.8 Cr |
| Cash Flow after changes in Working Capital | 9.62 Cr | 80.16 Cr | 8.75 Cr | 3.29 Cr |
| Cash Flow from Operating Activities | 8.81 Cr | 79.25 Cr | 8.95 Cr | 1.77 Cr |
| Cash Flow from Investing Activities | -16.13 Lk | -6.17 Cr | 7.35 Cr | -9.49 Cr |
| Cash Flow from Financing Activitie | -11.8 Cr | -63.18 Cr | -21.64 Cr | 1.95 Cr |
| Net Cash Inflow / Outflow | -3.15 Cr | 9.9 Cr | -5.34 Cr | -5.76 Cr |
| Opening Cash & Cash Equivalents | 10.3 Cr | 7.15 Cr | 17.05 Cr | 11.71 Cr |
| Closing Cash & Cash Equivalent | 7.15 Cr | 17.05 Cr | 11.71 Cr | 5.95 Cr |
STANDALONE CASH FLOW FOR LYKA LABS LIMITED
| Year End | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|---|
| No of Months | 12 months | 12 months | 12 months | 12 months |
| Profit Before Tax | -18.4 Cr | 60.24 Cr | -13.21 Cr | -93.25 Lk |
| Adjustment | 33.97 Cr | 37.6 Cr | 31.31 Cr | 16.66 Cr |
| Changes In working Capital | -9.1 Cr | -20.76 Cr | -10.81 Cr | -11.16 Cr |
| Cash Flow after changes in Working Capital | 6.47 Cr | 77.08 Cr | 7.29 Cr | 4.56 Cr |
| Cash Flow from Operating Activities | 5.75 Cr | 76.53 Cr | 6.87 Cr | 3.09 Cr |
| Cash Flow from Investing Activities | 12.68 Lk | -4.33 Cr | 6.77 Cr | -8.61 Cr |
| Cash Flow from Financing Activitie | -7.75 Cr | -63.35 Cr | -20.33 Cr | 2.71 Cr |
| Net Cash Inflow / Outflow | -1.88 Cr | 8.85 Cr | -6.69 Cr | -2.81 Cr |
| Opening Cash & Cash Equivalents | 8.4 Cr | 6.53 Cr | 15.38 Cr | 8.7 Cr |
| Closing Cash & Cash Equivalent | 6.53 Cr | 15.38 Cr | 8.7 Cr | 5.89 Cr |
CONSOLIDATED BALANCE SHEET FOR LYKA LABS LIMITED
| YEAR | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|---|
| Share Capital | 28.69 Cr | 28.69 Cr | 30.69 Cr | 33.09 Cr |
| Equity - Authorised | 48 Cr | 48 Cr | 48 Cr | 48 Cr |
| Equity - Issued | 28.69 Cr | 28.69 Cr | 30.69 Cr | 33.09 Cr |
| Equity Paid Up | 28.69 Cr | 28.69 Cr | 30.69 Cr | 33.09 Cr |
| Face Value | 10 | 10 | 10 | 10 |
| Total Reserves | -54.49 Cr | -15.35 Cr | -2.69 Cr | 26 Cr |
| Securities Premium | 97.44 Cr | 97.44 Cr | 123.34 Cr | 154.42 Cr |
| Capital Reserves | 49.13 Lk | 49.13 Lk | 49.13 Lk | 49.13 Lk |
| Profit & Loss Account Balance | -161.45 Cr | -122.45 Cr | -135.66 Cr | -138.15 Cr |
| General Reserves | 9.53 Cr | 9.53 Cr | 9.53 Cr | 9.53 Cr |
| Reserve excluding Revaluation Reserve | -54.49 Cr | -15.35 Cr | -2.69 Cr | 26 Cr |
| Shareholder's Funds | -25.8 Cr | 13.34 Cr | 45.44 Cr | 68.15 Cr |
| Minority Interest | 70.43 Lk | 15.25 Lk | 23.01 Lk | 11.11 Lk |
| Secured Loans | 150.65 Cr | 85.86 Lk | 38.59 Lk | 7.18 Cr |
| Term Loans - Banks | 0 | 0 | 0 | 7.18 Cr |
| Unsecured Loans | 70.68 Lk | 61.63 Cr | 63.4 Cr | 35.73 Cr |
| Loans - Others | 0 | 60.85 Cr | 62.32 Cr | 34.65 Cr |
| Deferred Tax Assets / Liabilities | -16.35 Cr | 4.23 Cr | 4.01 Cr | 3.83 Cr |
| Deferred Tax Assets | 16.35 Cr | 3.13 Cr | 1.01 Cr | 90.65 Lk |
| Deferred Tax Liability | 0 | 7.37 Cr | 5.02 Cr | 4.73 Cr |
| Other Long Term Liabilities | 10.84 Cr | 2.58 Cr | 3.02 Cr | 2.26 Cr |
| Long Term Provisions | 3.66 Cr | 3.47 Cr | 2.44 Cr | 1.82 Cr |
| Total Non-Current Liabilities | 149.52 Cr | 72.77 Cr | 73.25 Cr | 50.82 Cr |
| Trade Payables | 14.72 Cr | 12 Cr | 9.41 Cr | 12.1 Cr |
| Sundry Creditors | 14.72 Cr | 12 Cr | 9.41 Cr | 12.1 Cr |
| Other Current Liabilities | 22.45 Cr | 66.25 Cr | 14.35 Cr | 12.41 Cr |
| Bank Overdraft / Short term credit | 9,000 | 0 | 0 | 30.52 Lk |
| Advances received from customers | 9.34 Cr | 3.6 Cr | 96.66 Lk | 56.32 Lk |
| Interest Accrued But Not Due | 3.67 Cr | 81.01 Lk | 2.48 Cr | 19.85 Lk |
| Current maturity of Debentures & Bonds | 13 Lk | 13 Lk | 13 Lk | 13 Lk |
| Current maturity - Others | 13.08 Lk | 36.25 Lk | 27.74 Lk | 0 |
| Short Term Borrowings | 10.37 Cr | 20.07 Cr | 7.64 Cr | 11.61 Cr |
| Secured ST Loans repayable on Demands | 1.03 Cr | 3.82 Cr | 3.21 Cr | 10.11 Cr |
| Working Capital Loans- Sec | 1.03 Cr | 3.82 Cr | 3.21 Cr | 10.11 Cr |
| Short Term Provisions | 1.7 Cr | 1.05 Cr | 1.2 Cr | 1.52 Cr |
| Provision for post retirement benefits | 10.12 Lk | 8.31 Lk | 0 | 0 |
| Total Current Liabilities | 49.24 Cr | 99.35 Cr | 32.6 Cr | 37.64 Cr |
| Total Liabilities | 173.67 Cr | 185.61 Cr | 151.52 Cr | 156.72 Cr |
| Gross Block | 202.5 Cr | 169.37 Cr | 157.96 Cr | 160.37 Cr |
| Less: Accumulated Depreciation | 104.31 Cr | 75.41 Cr | 89.87 Cr | 102.67 Cr |
| Net Block | 98.19 Cr | 93.96 Cr | 68.1 Cr | 57.7 Cr |
| Capital Work in Progress | 16.18 Cr | 16.23 Cr | 15.1 Cr | 21.97 Cr |
| Non Current Investments | 89,000 | 89,000 | 3.99 Lk | 7.47 Lk |
| Long Term Investment | 89,000 | 89,000 | 3.99 Lk | 7.47 Lk |
| Quoted | 88,000 | 88,000 | 3.98 Lk | 7.46 Lk |
| Unquoted | 1,000 | 1,000 | 1,000 | 1,000 |
| Long Term Loans & Advances | 20.59 Cr | 21.71 Cr | 22.96 Cr | 25.25 Cr |
| Total Non-Current Assets | 144.54 Cr | 133.42 Cr | 107.32 Cr | 106.07 Cr |
| Currents Investments | 77,000 | 80,000 | 84,000 | 1.71 Lk |
| Unquoted | 1,000 | 1,000 | 1,000 | 1,000 |
| Inventories | 4.31 Cr | 8.2 Cr | 6.95 Cr | 9.57 Cr |
| Raw Materials | 1.96 Cr | 3.13 Cr | 2.29 Cr | 3.6 Cr |
| Work-in Progress | 26.77 Lk | 38.79 Lk | 70.81 Lk | 34.45 Lk |
| Finished Goods | 18.9 Lk | 47.93 Lk | 1.37 Cr | 2.52 Cr |
| Packing Materials | 1.89 Cr | 4.2 Cr | 2.59 Cr | 3.11 Cr |
| Sundry Debtors | 8.67 Cr | 18.45 Cr | 20.13 Cr | 26.99 Cr |
| Debtors more than Six months | 0 | 5.05 Cr | 6.46 Cr | 7.5 Cr |
| Debtors Others | 12.21 Cr | 16.92 Cr | 17.13 Cr | 22.91 Cr |
| Cash and Bank | 7.15 Cr | 17.05 Cr | 11.71 Cr | 5.95 Cr |
| Cash in hand | 84,000 | 1.54 Lk | 7.4 Lk | 7.78 Lk |
| Balances at Bank | 7.15 Cr | 17.04 Cr | 11.64 Cr | 5.87 Cr |
| Other Current Assets | 4.73 Cr | 2.87 Cr | 2.93 Cr | 3.34 Cr |
| Prepaid Expenses | 1.95 Cr | 1.43 Cr | 61.84 Lk | 25.76 Lk |
| Short Term Loans and Advances | 4.26 Cr | 5.62 Cr | 2.48 Cr | 4.78 Cr |
| Advances recoverable in cash or in kind | 1.67 Cr | 1.54 Cr | 25.06 Lk | 57.73 Lk |
| Advance income tax and TDS | 4.28 Lk | 0 | 2.22 Lk | 0 |
| Total Current Assets | 29.12 Cr | 52.2 Cr | 44.2 Cr | 50.65 Cr |
| Net Current Assets (Including Current Investments) | -20.12 Cr | -47.15 Cr | 11.61 Cr | 13.01 Cr |
| Total Assets | 173.67 Cr | 185.61 Cr | 151.52 Cr | 156.72 Cr |
| Contingent Liabilities | 40.85 Cr | 44.23 Cr | 35.08 Cr | 32.6 Cr |
| Total Debt | 162.41 Cr | 130.15 Cr | 72.18 Cr | 56.7 Cr |
| Book Value | -8.99 | 4.65 | 9.12 | 17.86 |
| Adjusted Book Value | -8.99 | 4.65 | 9.12 | 17.86 |
STANDALONE BALANCE SHEET FOR LYKA LABS LIMITED
| YEAR | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|---|
| Share Capital | 28.69 Cr | 28.69 Cr | 30.69 Cr | 33.09 Cr |
| Equity - Authorised | 48 Cr | 48 Cr | 48 Cr | 48 Cr |
| Equity - Issued | 28.69 Cr | 28.69 Cr | 30.69 Cr | 33.09 Cr |
| Equity Paid Up | 28.69 Cr | 28.69 Cr | 30.69 Cr | 33.09 Cr |
| Face Value | 10 | 10 | 10 | 10 |
| Total Reserves | -24.28 Cr | 15.75 Cr | 28.3 Cr | 57.17 Cr |
| Securities Premium | 97.44 Cr | 97.44 Cr | 123.34 Cr | 154.42 Cr |
| Capital Reserves | 50.68 Lk | 50.68 Lk | 50.68 Lk | 50.68 Lk |
| Profit & Loss Account Balance | -127.99 Cr | -88.09 Cr | -101.38 Cr | -103.65 Cr |
| General Reserves | 6.25 Cr | 6.25 Cr | 6.25 Cr | 6.25 Cr |
| Reserve excluding Revaluation Reserve | -24.28 Cr | 15.75 Cr | 28.3 Cr | 57.17 Cr |
| Shareholder's Funds | 4.41 Cr | 44.44 Cr | 76.43 Cr | 99.33 Cr |
| Secured Loans | 150.35 Cr | 0 | 0 | 7.18 Cr |
| Term Loans - Banks | 0 | 0 | 0 | 7.18 Cr |
| Unsecured Loans | 70.68 Lk | 61.63 Cr | 63.4 Cr | 35.73 Cr |
| Loans - Others | 0 | 60.85 Cr | 62.32 Cr | 34.65 Cr |
| Deferred Tax Assets / Liabilities | -16.22 Cr | 4.12 Cr | 3.99 Cr | 3.73 Cr |
| Deferred Tax Assets | 16.22 Cr | 2.97 Cr | 91.11 Lk | 88.22 Lk |
| Deferred Tax Liability | 0 | 7.08 Cr | 4.9 Cr | 4.61 Cr |
| Other Long Term Liabilities | 10.47 Cr | 2.21 Cr | 2.95 Cr | 2.4 Cr |
| Long Term Provisions | 2.68 Cr | 2.44 Cr | 2.13 Cr | 1.74 Cr |
| Total Non-Current Liabilities | 147.99 Cr | 70.4 Cr | 72.46 Cr | 50.78 Cr |
| Trade Payables | 12.02 Cr | 8.68 Cr | 8.23 Cr | 10.91 Cr |
| Sundry Creditors | 12.02 Cr | 8.68 Cr | 8.23 Cr | 10.91 Cr |
| Other Current Liabilities | 21.02 Cr | 64.08 Cr | 12.93 Cr | 11.77 Cr |
| Bank Overdraft / Short term credit | 9,000 | 0 | 1.72 Cr | 25.18 Lk |
| Advances received from customers | 8.88 Cr | 1.66 Cr | 71.65 Lk | 47.24 Lk |
| Interest Accrued But Not Due | 3.05 Cr | 52.38 Lk | 2.48 Cr | 19.85 Lk |
| Current maturity of Debentures & Bonds | 13 Lk | 13 Lk | 13 Lk | 13 Lk |
| Current maturity - Others | 2.99 Lk | 0 | 0 | 0 |
| Short Term Borrowings | 10.09 Cr | 19.9 Cr | 7.64 Cr | 11.61 Cr |
| Secured ST Loans repayable on Demands | 86.02 Lk | 3.65 Cr | 3.21 Cr | 10.11 Cr |
| Working Capital Loans- Sec | 86.02 Lk | 3.65 Cr | 3.21 Cr | 10.11 Cr |
| Short Term Provisions | 1.62 Cr | 1.02 Cr | 1.17 Cr | 1.49 Cr |
| Provision for post retirement benefits | 10.12 Lk | 8.31 Lk | 0 | 0 |
| Total Current Liabilities | 44.75 Cr | 93.68 Cr | 29.97 Cr | 35.78 Cr |
| Total Liabilities | 197.15 Cr | 208.51 Cr | 178.86 Cr | 185.88 Cr |
| Gross Block | 162.94 Cr | 171.88 Cr | 153.6 Cr | 156 Cr |
| Less: Accumulated Depreciation | 67.6 Cr | 81.76 Cr | 88.07 Cr | 100.36 Cr |
| Net Block | 95.34 Cr | 90.11 Cr | 65.53 Cr | 55.64 Cr |
| Capital Work in Progress | 16.18 Cr | 16.23 Cr | 15.1 Cr | 21.97 Cr |
| Non Current Investments | 32.4 Cr | 32.4 Cr | 32.4 Cr | 32.4 Cr |
| Long Term Investment | 32.4 Cr | 32.4 Cr | 32.4 Cr | 32.4 Cr |
| Unquoted | 32.4 Cr | 32.4 Cr | 32.4 Cr | 32.4 Cr |
| Long Term Loans & Advances | 19.28 Cr | 20.34 Cr | 22.41 Cr | 24.92 Cr |
| Total Non-Current Assets | 171.42 Cr | 160.6 Cr | 136.56 Cr | 136.02 Cr |
| Currents Investments | 77,000 | 80,000 | 84,000 | 1.71 Lk |
| Unquoted | 32.4 Cr | 32.4 Cr | 32.4 Cr | 32.4 Cr |
| Inventories | 4.3 Cr | 8.18 Cr | 6.94 Cr | 9.56 Cr |
| Raw Materials | 1.96 Cr | 3.13 Cr | 2.29 Cr | 3.6 Cr |
| Work-in Progress | 26.77 Lk | 38.79 Lk | 70.81 Lk | 34.45 Lk |
| Finished Goods | 18.14 Lk | 46.56 Lk | 1.35 Cr | 2.5 Cr |
| Packing Materials | 1.89 Cr | 4.2 Cr | 2.59 Cr | 3.11 Cr |
| Sundry Debtors | 9.9 Cr | 17.59 Cr | 17.16 Cr | 25.73 Cr |
| Debtors more than Six months | 0 | 1.81 Cr | 3.45 Cr | 4.49 Cr |
| Debtors Others | 10.35 Cr | 16 Cr | 14.06 Cr | 21.6 Cr |
| Cash and Bank | 6.53 Cr | 15.38 Cr | 8.7 Cr | 5.89 Cr |
| Cash in hand | 70,000 | 1.53 Lk | 7.39 Lk | 7.77 Lk |
| Balances at Bank | 6.52 Cr | 15.37 Cr | 8.62 Cr | 5.81 Cr |
| Other Current Assets | 2.42 Cr | 2.21 Cr | 2.32 Cr | 2.76 Cr |
| Prepaid Expenses | 1.93 Cr | 1.39 Cr | 61.19 Lk | 25.31 Lk |
| Short Term Loans and Advances | 2.58 Cr | 4.54 Cr | 7.17 Cr | 5.92 Cr |
| Advances recoverable in cash or in kind | 1.16 Cr | 1.42 Cr | 12.98 Lk | 46.87 Lk |
| Total Current Assets | 25.74 Cr | 47.91 Cr | 42.3 Cr | 49.86 Cr |
| Net Current Assets (Including Current Investments) | -19.02 Cr | -45.77 Cr | 12.33 Cr | 14.09 Cr |
| Total Assets | 197.15 Cr | 208.51 Cr | 178.86 Cr | 185.88 Cr |
| Contingent Liabilities | 40.85 Cr | 43.33 Cr | 35.08 Cr | 32.6 Cr |
| Total Debt | 161.73 Cr | 128.76 Cr | 71.51 Cr | 56.7 Cr |
| Book Value | 1.54 | 15.49 | 19.22 | 27.28 |
| Adjusted Book Value | 1.54 | 15.49 | 19.22 | 27.28 |
FINANCIAL RATIOS (CONSOLIDATED) FOR LYKA LABS LIMITED
| YEAR | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|---|
| Operational & Financial Ratios | ||||
| Earnings Per Share (Rs) | -4.03 | 13.59 | -4.3 | -0.75 |
| CEPS(Rs) | -0.62 | 19.45 | 0.32 | 3.08 |
| Book NAV/Share(Rs) | -8.99 | 4.65 | 9.12 | 17.86 |
| Tax Rate(%) | 28.66 | 35.11 | 0.14 | -180.63 |
| Margin Ratios | ||||
| Core EBITDA Margin(%) | 22.82 | 52.12 | 18.09 | 14.13 |
| EBIT Margin(%) | 13.67 | 40.9 | -1.4 | 3.56 |
| Pre Tax Margin(%) | -16.4 | 30.53 | -14.15 | -0.84 |
| PAT Margin (%) | -11.7 | 19.81 | -14.13 | -2.36 |
| Cash Profit Margin (%) | -2.05 | 28.75 | 1.07 | 9.16 |
| Performance Ratios | ||||
| ROA(%) | -5.58 | 21.4 | -7.8 | -1.7 |
| ROE(%) | 0 | 0 | -63.63 | -6.02 |
| ROCE(%) | 8.95 | 56.68 | -1 | 3.26 |
| Asset Turnover(x) | 0.48 | 1.08 | 0.55 | 0.72 |
| Sales/Fixed Asset(x) | 0.44 | 1.04 | 0.56 | 0.7 |
| Working Capital/Sales(x) | -4.29 | -4.12 | 8.02 | 8.55 |
| Efficiency Ratios | ||||
| Fixed Capital/Sales(x) | 2.27 | 0.96 | 1.8 | 1.43 |
| Receivable days | 35.37 | 25.51 | 75.65 | 77.33 |
| Inventory Days | 23.36 | 11.76 | 29.71 | 27.12 |
| Payable days | 90.59 | 92.01 | 104 | 87.52 |
| Valuation Parameters | ||||
| PER(x) | 0 | 9.98 | 0 | 0 |
| PCE(x) | -42.22 | 6.97 | 322.97 | 34.43 |
| Price/Book(x) | -2.89 | 29.17 | 11.47 | 5.93 |
| EV/Net Sales(x) | 2.66 | 2.59 | 4.1 | 3.61 |
| EV/Core EBITDA(x) | 10.82 | 4.86 | 18.86 | 23.38 |
| EV/EBIT(x) | 19.49 | 6.33 | -293.5 | 101.42 |
| EV/CE(x) | 1.32 | 2.71 | 2.52 | 3.21 |
| M Cap / Sales | 0.86 | 2 | 3.45 | 3.15 |
| Growth Ratio | ||||
| Net Sales Growth(%) | 40.27 | 125.02 | -52.05 | 19.47 |
| Core EBITDA Growth(%) | 3765.51 | 385.97 | -80.4 | -15.17 |
| EBIT Growth(%) | 128.21 | 573.04 | -101.64 | 404.21 |
| PAT Growth(%) | 83.89 | 480.98 | -134.21 | 80.08 |
| EPS Growth(%) | 80.91 | 437.53 | -131.67 | 82.52 |
| Financial Stability Ratios | ||||
| Total Debt/Equity(x) | -6.3 | 9.76 | 2.58 | 0.96 |
| Current Ratio(x) | 0.59 | 0.53 | 1.36 | 1.35 |
| Quick Ratio(x) | 0.5 | 0.44 | 1.14 | 1.1 |
| Interest Cover(x) | 0.45 | 3.94 | -0.11 | 0.81 |
| Total Debt/Mcap(x) | 2.18 | 0.33 | 0.22 | 0.16 |
FINANCIAL RATIOS (STANDALONE) FOR LYKA LABS LIMITED
| YEAR | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|---|
| Operational & Financial Ratios | ||||
| Earnings Per Share (Rs) | -5.04 | 13.91 | -4.33 | -0.69 |
| CEPS(Rs) | -2.23 | 19.27 | 0.07 | 3.03 |
| Book NAV/Share(Rs) | 1.54 | 15.49 | 19.22 | 27.28 |
| Tax Rate(%) | 21.4 | 33.76 | -0.59 | -143.31 |
| Margin Ratios | ||||
| Core EBITDA Margin(%) | 23.17 | 59.32 | 19.36 | 13.69 |
| EBIT Margin(%) | 11.5 | 48.78 | -2.03 | 3.63 |
| Pre Tax Margin(%) | -29.54 | 36.65 | -16.39 | -0.88 |
| PAT Margin (%) | -23.22 | 24.28 | -16.49 | -2.13 |
| Cash Profit Margin (%) | -10.29 | 33.64 | 0.29 | 9.42 |
| Performance Ratios | ||||
| ROA(%) | -7.12 | 19.67 | -6.86 | -1.24 |
| ROE(%) | -124.71 | 163.37 | -25.69 | -3.04 |
| ROCE(%) | 4.45 | 47.25 | -1.02 | 2.54 |
| Asset Turnover(x) | 0.31 | 0.81 | 0.42 | 0.58 |
| Sales/Fixed Asset(x) | 0.41 | 0.98 | 0.5 | 0.69 |
| Working Capital/Sales(x) | -3.27 | -3.59 | 6.54 | 7.55 |
| Efficiency Ratios | ||||
| Fixed Capital/Sales(x) | 2.44 | 1.02 | 2.02 | 1.45 |
| Receivable days | 48.35 | 30.52 | 78.69 | 73.57 |
| Inventory Days | 29.33 | 13.86 | 34.25 | 28.3 |
| Payable days | 102.47 | 122.42 | 106.2 | 81.33 |
| Valuation Parameters | ||||
| PER(x) | 0 | 9.75 | 0 | 0 |
| PCE(x) | -11.64 | 7.04 | 1398.28 | 35 |
| Price/Book(x) | 16.92 | 8.75 | 5.45 | 3.88 |
| EV/Net Sales(x) | 3.69 | 3.06 | 4.77 | 3.77 |
| EV/Core EBITDA(x) | 13.81 | 5.01 | 20.16 | 24.77 |
| EV/EBIT(x) | 32.11 | 6.27 | -234.46 | 103.85 |
| EV/CE(x) | 1.17 | 2.41 | 2.15 | 2.57 |
| M Cap / Sales | 1.2 | 2.37 | 3.99 | 3.3 |
| Growth Ratio | ||||
| Net Sales Growth(%) | 52.82 | 163.96 | -50.96 | 32.02 |
| Core EBITDA Growth(%) | 2785.81 | 502.43 | -80.99 | -14.93 |
| EBIT Growth(%) | 119.81 | 1019.97 | -102.04 | 335.93 |
| PAT Growth(%) | 73.89 | 375.97 | -133.3 | 82.92 |
| EPS Growth(%) | 73.89 | 375.97 | -131.13 | 84.16 |
| Financial Stability Ratios | ||||
| Total Debt/Equity(x) | 36.68 | 2.9 | 1.21 | 0.63 |
| Current Ratio(x) | 0.58 | 0.51 | 1.41 | 1.39 |
| Quick Ratio(x) | 0.48 | 0.42 | 1.25 | 1.13 |
| Interest Cover(x) | 0.28 | 4.02 | -0.14 | 0.81 |
| Total Debt/Mcap(x) | 2.17 | 0.33 | 0.22 | 0.16 |
SHARE HOLDING PATTERN FOR LYKA LABS LIMITED
| Date | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoters % | 47.80 | 47.59 | 47.59 | 51.00 | 54.58 | 54.81 | 54.81 | 54.81 | 58.10 | 58.10 |
| FII % | 0.76 | 0.57 | 0.37 | 0.18 | 0.17 | 0.18 | 0.17 | 0.17 | 0.15 | 0.15 |
| DII % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.21 | 0.40 | 0.37 | 0.37 |
| Public % | 47.45 | 47.84 | 48.05 | 45.08 | 44.85 | 44.60 | 44.40 | 44.21 | 40.99 | 41.08 |
PEER COMPARISON FOR LYKA LABS LIMITED
CORPORATE ACTIONS FOR LYKA LABS
| Exchange Date | Purpose | Book Closure Dates |
|---|---|---|
| BSE 22-Oct-2024 | Board Meeting - Quarterly Results | 12-Nov-2024 |
| BSE 04-Oct-2024 | Board Meeting - Inter-alia, to consider and approve filling of fresh application of scheme of amalgamation of Lyka Exports Limited (Company?s subsidiary) with the Company with the Hon?able National Company Law Tribunal Division Bench, Court - I, Ahmedabad ( the NCLT) in terms of the Order dated 24th September, 2024 passed by the NCLT. | 11-Oct-2024 |
| BSE 01-Aug-2024 | Board Meeting - Quarterly Results | 09-Aug-2024 |
| BSE 15-Jul-2024 | Book Closure - A.G.M. | 02-Aug-2024 09-Aug-2024 |
| BSE 15-Jul-2024 | AGM - A.G.M. | 09-Aug-2024 09-Aug-2024 |
| BSE 10-May-2024 | Board Meeting - Audited Results | 21-May-2024 |
| BSE 08-Apr-2024 | Board Meeting - Inter alia, to consider and approve :- (1) to allot and issue 2600000 equity shares upon conversion of 2600000 warrants to Ipca Laboratories Limited. | 16-Apr-2024 |
| BSE 31-Jan-2024 | Board Meeting - Quarterly Results | 08-Feb-2024 |
| BSE 20-Oct-2023 | Board Meeting - Quarterly Results | 02-Nov-2023 |
| BSE 26-Jul-2023 | Board Meeting - Quarterly Results | 02-Aug-2023 |
| BSE 10-Jul-2023 | Book Closure - A.G.M. | 24-Jul-2023 01-Aug-2023 |
| BSE 10-Jul-2023 | AGM - A.G.M. | 01-Aug-2023 01-Aug-2023 |
| BSE 16-May-2023 | Board Meeting - Audited Results | 23-May-2023 |
| BSE 11-Apr-2023 | Board Meeting - Inter alia: to allot and issue 24,00,000 Equity Shares upon conversion of 24,00,000 Warrants to Ipca Laboratories Limited, part of a ?Promoter Group?. | 18-Apr-2023 |
| BSE 08-Mar-2023 | Board Meeting - Preferential Issue of shares & Issue Of Warrants Inter alia: to allot and issue 20,00,000 Equity Shares and 50,00,000 Warrants convertible into Equity Shares to Ipca Laboratories Limited and to approve draft of Postal Ballot Notice for seeking approval of shareholders for Re-appointment of Mr. Yogesh Shah as an Executive Director. | 15-Mar-2023 |
| BSE 31-Jan-2023 | Board Meeting - Quarterly Results | 07-Feb-2023 |
| BSE 18-Jan-2023 | Board Meeting - Issue Of Warrants & Preferential Issue of shares Inter alia to consider and evaluate proposal for raising of funds by way of issue of equity shares or any other eligible convertible securities, through permissible modes or combination of both, subject to all such regulatory/ statutory approvals as may be required including the approval of shareholders of the Company. | 21-Jan-2023 |
| BSE 09-Nov-2022 | SAST - Inter alia, approved:- 1. Noting resignation of Mr. Piyush G. Hindia, Company Secretary and Compliance officer of the Company. 2. Appointment of Mr. Kishore P. Shah, as Company Secretary and Compliance Officer of the Company. 3. Appointment of Mr. Kishore P. Shah, as Nodal Officer under Investor Education and Protection Fund (IEPF) Rules, 2016. 4. The Board has considered acquisition of animal hea... | 09-Nov-2022 |
| BSE 01-Nov-2022 | Board Meeting - Quarterly Results | 09-Nov-2022 |
| BSE 29-Aug-2022 | Board Meeting - Inter alia, to consider and approve: 1. Sale of Land at Dharampur, Valsad and premises situated at Shivshakti Industrial Estate, Andheri East. | 05-Sep-2022 |
| BSE 01-Aug-2022 | Board Meeting - Quarterly Results & Amalgamation | 08-Aug-2022 |
| BSE 25-May-2022 | Book Closure - A.G.M. | 25-Jul-2022 01-Aug-2022 |
| BSE 25-May-2022 | AGM - A.G.M. | 01-Aug-2022 01-Aug-2022 |
| BSE 20-May-2022 | Book Closure - A.G.M. | 29-Jul-2022 05-Aug-2022 |
| BSE 20-May-2022 | AGM - A.G.M. | 05-Aug-2022 05-Aug-2022 |
| BSE 13-May-2022 | Board Meeting - Audited Results | 20-May-2022 |
| BSE 13-Jan-2022 | Board Meeting - Quarterly Results | 20-Jan-2022 |
| BSE 03-Nov-2021 | Merger Demerger - inter alia, approved: 1. Merger of Lyka Exports Limited, a subsidiary Company with Lyka Labs Limited, Holding Company w.e.f 1st April, 2022 subject to requisite approval of Securities and Exchange Board of India (SEBI), and other applicable requisite authorities | 29-Oct-2021 |
| BSE 29-Oct-2021 | Merger Demerger - In Compliance with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015 the Board of Directors at its Meeting held todayconsidered Merger of Lyka Exports Limited, a subsidiary Company with Lyka Labs Limited, Holding Company w.e.f 01 April, 2022 subject to requisite approval ofSecurities and Exchange Board of India (SEBI),and other applicable requisite authoritie... | |
| BSE 22-Oct-2021 | Board Meeting - Quarterly Results | 29-Oct-2021 |
CORPORATE ANNOUNCEMENTS FOR LYKA LABS
| Exchange Date | Category File | Description |
|---|---|---|
| BSE 26-Oct-2024 | General Announcements FILE | Intimation Under Regulation 30 Of SEBI (LODR) Regulations 2015 - Update On The Scheme Of Amalgamation As per attachment |
| BSE 23-Oct-2024 | General Announcements FILE | Additional Details Required For Corporate Announcement Filed Under Regulation 30 Of SEBI (LODR) Regulations 2015 As per attachment |
| BSE 22-Oct-2024 | Intimation FILE | Board Meeting Intimation for Intimation Of The Board Meeting - 12Thnovember 2024 Ref.: Regulation 29(1)(A) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 LYKA LABS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2024 inter alia to consider and approve As per attachment. |
| BSE 14-Oct-2024 | General Announcements FILE | Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 (The LODR) As per attachment |
| BSE 11-Oct-2024 | Outcome FILE | Board Meeting Outcome for Outcome Of The Board Meeting -11Th October 2024 As per attachment |
| BSE 09-Oct-2024 | General Announcements FILE | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 As per attachment |
| BSE 04-Oct-2024 | Intimation FILE | Board Meeting Intimation for Notice Of The Board Meeting For Filling Fresh Application Of Amalgamation Of Lyka Exports Limited (Company'S Subsidiary) With The Company LYKA LABS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/10/2024 inter alia to consider and approve As per attachment |
| BSE 25-Sep-2024 | Intimation FILE | Closure of Trading Window The trading window for dealing in securities shall remain closed w.e.f. close of business hours on 30th September 2024 till the 48 hours after the declaration of unaudited financial results for the quarter ended 30th September 2024. |
| BSE 25-Sep-2024 | General Announcements FILE | Rejection Of The Company Petition Filed Under Sections 230 - 232 Of The Companies Act Rejection of the Company Petition filed under Sections 230-232 of the Companies Act |
| BSE 11-Sep-2024 | General Announcements FILE | Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate The Company submits the information about the loss of share certificates as detailed therein. |
| BSE 27-Aug-2024 | General Announcements FILE | Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate The Company submitted intimation about issue of duplicate share certificates as detailed therein. |
| BSE 23-Aug-2024 | General Announcements FILE | Updates On Scheme Of Amalgamation The Company updates on Scheme of Amalgamation as enclosed. |
| BSE 14-Aug-2024 | General Announcements FILE | Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate The Company inform issue of duplicate share certificates as detailed enclosed. |
| BSE 12-Aug-2024 | General Announcements FILE | Announcement under Regulation 30 (LODR)-Newspaper Publication The Company enclosed the newspaper publication of the unaudited standalone and consolidated financial results in newspapers as enclosed. |
| BSE 09-Aug-2024 | Outcome FILE | Shareholder Meeting / Postal Ballot-Scrutinizer''s Report Scrutinizer Report for the Annual General Meeting of the Company held on 09.08.2024 |
| BSE 09-Aug-2024 | Outcome FILE | Shareholder Meeting / Postal Ballot-Outcome of AGM Proceedings of Annual General Meeting held on 09th August 2024 |
| BSE 09-Aug-2024 | Compliance FILE | Statement Of Deviation Statement of Deviation quarter ended June 2024 |
| BSE 09-Aug-2024 | General Announcements FILE | Announcement under Regulation 30 (LODR)-Change in Management The Company has accept the Resignation of Mr. Kishore P. Shah Company Secretary and Compliance Officer of the Company. |
| BSE 09-Aug-2024 | Outcome FILE | Financial Results For The Quarter Ended 30.06.2024 Unaudited Financial Results for the quarter ended 30.06.2024 |
| BSE 09-Aug-2024 | Outcome FILE | Board Meeting Outcome for Outcome Of Board Meeting Outcome of Board Meeting held on 9th August 2024 |
| BSE 01-Aug-2024 | Intimation FILE | Board Meeting Intimation for Intimation Of Board Meeting LYKA LABS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/08/2024 inter alia to consider and approve The Company submit the details of Board Meeting to be held on 9th August 2024 as detailed therein. |
| BSE 23-Jul-2024 | General Announcements FILE | Update On The Scheme Of Amalgamation The Company submitted the updation on the NCLT hearing of the Scheme of Amalgamation as mentioned therein. |
| BSE 19-Jul-2024 | General Announcements FILE | Updates On Scheme Of Amalgamation The Company enclosed updates about the Scheme of Amalgamation as mentioned therein. |
| BSE 18-Jul-2024 | General Announcements FILE | Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate The Company submits the information about loss of share certificates through its Registrar and Transfer Agent as detailed therein. |
| BSE 18-Jul-2024 | Intimation FILE | Publication Of Notice Of 45Th Annual General Meeting Of The Company In The Newspapers. The Company enclosed the notice as published in the newspapers for the 45th Annual General Meeting of the Company |
| BSE 17-Jul-2024 | General Announcements FILE | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 The Company enclosed the Reconciliation of Share Capital Audit Report for the quarter ended on 30th June 2024. |
| BSE 16-Jul-2024 | Intimation FILE | Notice Of 45Th Annual General Meeting And Annual Report For The Financial Year 2023-24 The Company enclosed the notice of the 45th Annual General Meeting and the Annual Report for the Financial Year 2023-24. |
| BSE 16-Jul-2024 | General Announcements FILE | Newspaper Publication Of Advance Intimation Of Its 45Th Annual General Meeting Through VC/ OAVM. The Company enclosed the newspaper publication of advance intimation of its 45th Annual General Meeting to be held through VC/ OAVM |
| BSE 15-Jul-2024 | Intimation FILE | Book Closure Intimation For The Annual General Meeting Of The Company The Company inform the book closure for its Annual General Meeting as detailed therein. |
| BSE 11-Jul-2024 | General Announcements FILE | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 The Company enclosed a certificate for the quarter ended 30th June 2024 as received by its Registrar and Transfer Agent as detailed therein. |
INSIDER TRADING FOR LYKA LABS
| Exchange Dates | Activity | Qty & Price (%) | Person / Organisation |
|---|---|---|---|
| BSE 16-Apr-2024 16-Apr-2024 | Buy Others | 2,600,000 @ 0.00 (4.64 %) | Ipca Laboratories Ltd |
| BSE 22-Jun-2023 22-Jun-2023 | Buy Revocation Of Pledge | 4,600 @ 0.00 (0.01 %) | Nehal Narendra Gandhi |
| BSE 28-Jun-2023 28-Jun-2023 | Buy Revocation Of Pledge | 1,500 @ 0.00 (0.01 %) | Nehal Narendra Gandhi |
| BSE 14-Jun-2023 14-Jun-2023 | Buy Revocation Of Pledge | 900 @ 0.00 (0.00 %) | Nehal Narendra Gandhi |
| BSE 10-Jul-2023 10-Jul-2023 | Buy Revocation Of Pledge | 53,000 @ 0.00 (0.16 %) | Nehal Narendra Gandhi |
| BSE 27-Jun-2023 27-Jun-2023 | Buy Others | 1,350,000 @ 0.00 (4.08 %) | Kunal Gandhi |
| BSE 27-Jun-2023 27-Jun-2023 | Sell Others | 1,350,000 @ 0.00 (0.00 %) | Narendra I Gandhi HUF |
| BSE 18-Apr-2023 18-Apr-2023 | Buy Others | 2,400,000 @ 0.00 (4.98 %) | Ipca Laboratories Ltd |
| BSE 31-Mar-2023 31-Mar-2023 | Buy Others | 634,429 @ 0.00 (2.07 %) | Nehal Narendra Gandhi |
| BSE 31-Mar-2023 31-Mar-2023 | Sell Others | 634,429 @ 0.00 (0.00 %) | Narendra Ishwarlal Gandhi |
| BSE 29-Mar-2023 29-Mar-2023 | Sell Others | 148,000 @ 0.00 (0.48 %) | Narendra Ishwarlal Gandhi |
| BSE 29-Mar-2023 29-Mar-2023 | Buy Others | 148,000 @ 0.00 (0.48 %) | Nehal Narendra Gandhi |
| BSE 20-Mar-2023 20-Mar-2023 | Buy Inter-Se Transfer | 385,200 @ 0.00 (1.25 %) | Nehal Narendra Gandhi |
| BSE 15-Mar-2023 15-Mar-2023 | Buy Allotment | 2,000,000 @ 0.00 (4.78 %) | IPCA LABORATORIES LTD |
| BSE 15-Mar-2023 15-Mar-2023 | Buy Allotment | 5,000,000 @ 0.00 (0.00 %) | IPCA LABORATORIES LTD |
| BSE 04-Oct-2022 04-Oct-2022 | Buy Inter-Se Transfer | 50,776 @ 0.00 (0.18 %) | Kunal N Gandhi |
| BSE 04-Oct-2022 04-Oct-2022 | Sell Inter-Se Transfer | 50,776 @ 0.00 (0.17 %) | Narendra I Gandhi HUF |
| BSE 23-Feb-2022 23-Feb-2022 | Buy Others | 781 @ 0.00 (0.00 %) | Ipca Laboratories Ltd |
BULK BLOCK DEALS FOR LYKA LABS LIMITED
| Exchange Dates | Activity | Qty & Price (%) | Person / Organisation |
|---|---|---|---|
| BSE 02-Dec-2021 | Buy BULK | 7 @ 181.50 | MANSI SHARE & STOCK ADVISORS PRIVATE LIMITED |
| BSE 02-Dec-2021 | Sell BULK | 150,007 @ 181.50 | MANSI SHARE & STOCK ADVISORS PRIVATE LIMITED |
| BSE 01-Dec-2021 | Buy BULK | 214,000 @ 170.20 | BISHWANATH PRASAD AGARWAL |
| BSE 24-Nov-2021 | Buy BULK | 4,800,000 @ 130.40 | IPCA LABORATORIES LIMITED |
| BSE 24-Nov-2021 | Sell BULK | 1,800,000 @ 130.40 | MAYANK JASHWANTLAL SHAH |
| BSE 24-Nov-2021 | Sell BULK | 1,500,000 @ 130.40 | PRASHAM MAYANK SHAH |
| BSE 24-Nov-2021 | Sell BULK | 1,500,000 @ 130.40 | SHRUTI MAYANK SHAH |
| BSE 24-Nov-2021 | Buy BLOCK | 1,500,000 @ 130.40 | IPCA LABORATORIES LIMITED |
| BSE 24-Nov-2021 | Buy BLOCK | 1,800,000 @ 130.40 | IPCA LABORATORIES LIMITED |
| BSE 24-Nov-2021 | Sell BLOCK | 1,800,000 @ 130.40 | MAYANK JASHWANTLAL SHAH |
| BSE 24-Nov-2021 | Sell BLOCK | 1,500,000 @ 130.40 | PRASHAM MAYANK SHAH |
| BSE 24-Nov-2021 | Sell BLOCK | 1,500,000 @ 130.40 | SHRUTI MAYANK SHAH |
| BSE 23-Nov-2021 | Sell BULK | 975,356 @ 124.20 | AMEE PARIKH |
| BSE 23-Nov-2021 | Sell BULK | 798,786 @ 128.45 | DADAL&BROACHA STOCK BROKING PVT LTD |
| BSE 23-Nov-2021 | Buy BULK | 1,774,142 @ 126.11 | IPCA LABORATORIES LIMITED |
| BSE 23-Nov-2021 | Sell BLOCK | 975,356 @ 124.20 | AMEE PARIKH |
| BSE 23-Nov-2021 | Sell BLOCK | 798,786 @ 128.45 | DADAL&BROACHA STOCK BROKING PVT LTD |
| BSE 23-Nov-2021 | Buy BLOCK | 798,786 @ 128.45 | IPCA LABORATORIES LIMITED |
| BSE 23-Nov-2021 | Buy BLOCK | 975,356 @ 124.20 | IPCA LABORATORIES LIMITED |
| BSE 22-Nov-2021 | Buy BULK | 1,050,000 @ 123.00 | IPCA LABORATORIES LIMITED |
| BSE 22-Nov-2021 | Sell BULK | 345,000 @ 123.00 | SHREYANS JASHWANTLAL SHAH |
| BSE 22-Nov-2021 | Sell BULK | 240,121 @ 123.00 | VIPUL PRIYAKANT DALAL |
DIVIDEND BY LYKA LABS LIMITED
No dividend details found
SPLIT / BONUS BY LYKA LABS LIMITED
No Split / Bonus details found
Data feed Source : www.accordfintech.com, NSE DATA Feed & BSE Data Feed
